Are Thyroid Hormone and Tumor Cell Proliferation in Human Breast Cancers Positive for HER2 Associated?

Table 1

Comparison of thyroid hormone levels in breast cancer patients based on menopausal status, clinical stage, histopathological grade, and HER2 staining.

	Menopause				Significance
	No	Yes
FT3	2.97 (0.12)	2.92 (0.05)			= 0.66
FT4	1.39 (0.05)	1.36 (0.03)			= 0.60
TSH	1.67 (0.19)	1.58 (0.13)			= 0.70
	Clinical stage
	I	II	III	IV
FT3	2.88 (0.15)	2.95 (0.05)	2.95 (0.13)	2.97 (0.13)	= 0.94
FT4	1.36 (0.06)	1.38 (0.04)	1.36 (0.07)	1.32 (0.08)	= 0.90
TSH	1.35 (0.19)	1.58 (0.14)	2.04 (0.32)	1.85 (0.6)	= 0.27
	Histopathological grade
	Grade 1	Grade 2	Grade 3
FT3	2.77 (0.18)	2.95 (0.06)	2.97 (0.14)		= 0.59
FT4	1.26 (0.08)	1.36 (0.03)	1.45 (0.07)		= 0.26
TSH	2.18 (0.67)	1.64 (0.11)	1.21 (0.3)		= 0.16
	HER2 staining
	Negative	Positive
FT3	3.0 (0.07)	2.9 (0.06)			= 0.35
FT4	1.36 (0.06)	1.37 (0.03)			= 0.88
TSH	1.74 (0.25)	1.57 (0.12)			= 0.50